Keel Point LLC Makes New $291,000 Investment in The Allstate Co. (NYSE:ALL)

Keel Point LLC acquired a new stake in The Allstate Co. (NYSE:ALLFree Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 2,077 shares of the insurance provider’s stock, valued at approximately $291,000.

Other large investors also recently modified their holdings of the company. Gradient Investments LLC boosted its holdings in shares of Allstate by 1.6% during the 4th quarter. Gradient Investments LLC now owns 4,130 shares of the insurance provider’s stock worth $578,000 after buying an additional 66 shares during the period. Apollon Wealth Management LLC lifted its position in Allstate by 2.5% during the fourth quarter. Apollon Wealth Management LLC now owns 3,214 shares of the insurance provider’s stock worth $436,000 after acquiring an additional 78 shares during the last quarter. AdvisorNet Financial Inc boosted its holdings in shares of Allstate by 1.5% during the fourth quarter. AdvisorNet Financial Inc now owns 5,384 shares of the insurance provider’s stock worth $754,000 after acquiring an additional 82 shares during the period. Carmel Capital Partners LLC grew its position in shares of Allstate by 19.2% in the third quarter. Carmel Capital Partners LLC now owns 516 shares of the insurance provider’s stock valued at $57,000 after purchasing an additional 83 shares during the last quarter. Finally, Ballentine Partners LLC increased its stake in shares of Allstate by 0.8% during the third quarter. Ballentine Partners LLC now owns 11,320 shares of the insurance provider’s stock worth $1,261,000 after purchasing an additional 89 shares during the period. 76.47% of the stock is owned by institutional investors.

Allstate Stock Down 1.0 %

ALL stock opened at $164.13 on Wednesday. The firm has a 50-day moving average price of $163.35 and a 200-day moving average price of $146.33. The stock has a market capitalization of $43.18 billion, a P/E ratio of -132.36, a price-to-earnings-growth ratio of 0.41 and a beta of 0.52. The Allstate Co. has a 12 month low of $100.57 and a 12 month high of $174.57. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.51.

Allstate (NYSE:ALLGet Free Report) last posted its earnings results on Thursday, February 8th. The insurance provider reported $5.82 EPS for the quarter, beating the consensus estimate of $3.87 by $1.95. The firm had revenue of $14.83 billion during the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a positive return on equity of 2.67% and a negative net margin of 0.33%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned ($1.36) earnings per share. As a group, equities research analysts anticipate that The Allstate Co. will post 13.41 EPS for the current fiscal year.

Allstate Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend was Friday, March 1st. This is a positive change from Allstate’s previous quarterly dividend of $0.89. Allstate’s payout ratio is -296.77%.

Wall Street Analyst Weigh In

A number of brokerages have commented on ALL. Jefferies Financial Group raised Allstate from a “hold” rating to a “buy” rating and upped their price objective for the company from $130.00 to $180.00 in a report on Tuesday, January 9th. Evercore ISI boosted their target price on shares of Allstate from $166.00 to $173.00 and gave the company an “in-line” rating in a research report on Thursday, April 11th. JPMorgan Chase & Co. raised their price target on shares of Allstate from $172.00 to $185.00 and gave the stock an “overweight” rating in a research report on Monday, April 8th. Morgan Stanley lifted their price objective on shares of Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, Keefe, Bruyette & Woods increased their target price on shares of Allstate from $181.00 to $189.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Allstate currently has an average rating of “Moderate Buy” and an average target price of $173.71.

Get Our Latest Report on ALL

Insider Buying and Selling

In related news, CAO John C. Pintozzi sold 4,000 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CAO John C. Pintozzi sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares in the company, valued at $1,712,069.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the transaction, the insider now directly owns 63,731 shares in the company, valued at $10,847,016.20. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by insiders.

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.